Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Loretta J. Nastoupil, Clark Andersen,Amy Ayers, Yucai Wang,Thomas M. Habermann,Dai Chihara,Brad S. Kahl,Brian K. Link,Sabarish Ayyappan,Jonathon B. Cohen,Peter Martin,Izidore S. Lossos,Carla Casulo,Ruitao Lin,Ziyi Li, Melissa A. Larson,Matthew J. Maurer,Lynn Huynh, Chi Gao,Ramya Ramasubramanian,Mei Sheng Duh,Alex Mutebi, Tongsheng Wang,Monika Jun,Anthony Wang,Rajesh Kamalakar,Anupama Kalsekar,James R. Cerhan,Christopher R. Flowers CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
lbcl,real-world,b-cell,chemo-immunotherapy
AI 理解论文
溯源树
样例
